GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$32.47
Tradestie Score
41
Market Cap
$19.56B
P/E Ratio
26.2
Revenue Growth
0.2%
Analyst Upside
+19.6%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$96.73
|
$24.57B | - | 37 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.47
|
$16.93B | 16.1 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.61
|
$15.70B | 32.6 | 52 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.55
|
$15.22B | - | 41 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$263.52
|
$12.36B | 20.1 | 47 | Compare |
|
EXEL
Exelixis Inc
|
$56.12
|
$11.09B | 18.3 | 41 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$40.82
|
$10.76B | - | 39 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$143.97
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$65.68
|
$10.53B | 177.1 | 58 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.21
|
$10.49B | - | 50 | Compare |
More GMAB Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry